top of page
Alzheimer’s 101
Personal Stories
Improving Access to Innovations
Key Updates & Events
More
Use tab to navigate through the menu items.
Search
All Posts
FDA clears first blood test for diagnosing Alzheimer’s
May 15
Medicare must ensure access to groundbreaking Alzheimer’s treatments for Nevadans
Nov 27, 2024
Polling Reveals Americans Back Alzheimer's Patients
Nov 27, 2024
Medicare's Patient Registry Is Slowing Alzheimer’s Treatment Access
Nov 22, 2024
Advocates Push Candidates on Alzheimer’s Care
Oct 30, 2024
Bipartisan Majority Believes Medicare Beneficiaries Should Have Access to FDA-approved Early Alzheimer’s Medications the Same Way They Do for All Other Diseases
Oct 9, 2024
Access to new Alzheimer’s treatments bogged down by Medicare policy
Jun 16, 2024
Medicare’s Alzheimer's math is fuzzy -- but critics are missing the bigger picture
May 13, 2024
How donanemab data address the coverage with evidence development questions
Feb 1, 2024
Alzheimer’s Discrimination Continues in More Ways Than One (12/19/23)
Dec 19, 2023
Sue Glick Peschin, Celinda Lake and Neil Newhouse: Americans agree: Medicare's unfair on Alzheimer's treatment
Jun 18, 2023
bottom of page